Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on July 27, 2016. The report serves to disclose the company's financial results for the second quarter ended June 30, 2016, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not explicitly detailed in the body of this 8-K document.
Material Changes
The filing does not list specific material changes versus the prior comparable period. It solely references the issuance of the Q2 2016 results press release.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 27, 2016) for actual Q2 2016 financial figures.
- Verify the specific revenue, earnings per share, and margin data in the referenced press release.
- Confirm any forward-looking statements or guidance provided in the press release, as they are not present in this 8-K summary.
- Note that the registrant name at the time of filing was Anthem, Inc.